Stallion labs has been manufacturing Levetiracetam since 2009. In 15 years they should already have a large market share.
It is my understanding SHMN now has the exclusive rights to distribute the Stallion brand of the drug to the share of the market Stallion has already established. I also believe that if Stallion thought SHMN didn't have the distribution capabilities they wouldn't have struck an exclusive deal with them to do so.
$SHMN:MDP: You're running too many ASSUMPTIONS... just pure B.S & guessing! 1. Stallion Labs chose $SHMN as their SOLE distributor in N.America (that's a huge mkt) 2. Vol & Vol discounts are a Non-Issue. You need to check out the company (Stallion Labs). They'll provide both, 3. Medical Facility? $SHMN PR'd in Dec '23 that they've been REGISTERED with the U.S. FDA as both mfg & distribution facility. So it's a NON-ISSUE!
The issues that I (&others) have are:- 1. Need Ms. Jacob to be Pro-Active & get the website updated, as a real co. with RESEARCH FACILITIES! I believe that's ONE of her core responsibilities 2. Barron & Tony need to update S/Hs on sales & mkt initiatives. I believe Tony's core responsibility is sales (subset of Finance) 3. As was obvious Dr. Aguilar & Gallegos have been grinding away. Thank you to both! And Aguilar...looks to be working on the mkt too!
We're past the '90' day review period. So it's TIME to REVIEW PERFORMANCE! This is NOT the FEDERAL GOVT!
News 
Market Data 
Discover 
